Christine P. Bump
Principal, Penn Avenue Law & Policy
Christine P. Bump is an insightful regulatory attorney with more than 15 years of experience developing and implementing FDA strategies for cutting-edge technology. She focuses on regulatory issues relating to devices, diagnostics, genetics and genomics, digital health, wellness, and advertising and promotion. Christine counsels laboratories, start-ups, and large corporations, and advises clients with an awareness and understanding of their business and strategic goals. She has prepared clinical trial and customer user agreements for laboratory and wellness products, with emphasis on patient and data privacy.
Christine has also developed regulatory strategies for new technologies related to IVF and pre-implantation selection, and served as dedicated counsel to a fertility clinic. Her policy experience includes serving as a regulatory counsel for a national coalition of diagnostic companies. She has prepared unified comments on behalf of a coalition to FDA and Congress, and prepared lobbyists for meetings on Capitol Hill regarding alternatives to existing and proposed regulations.
- Food and Drug Law
- District of Columbia
- District of Columbia Bar
- Georgia
- Vice President
- Goldbug Strategies LLC
- -
- Senior Associate
- Goodwin Procter LLP
- -
- Associate
- Hyman, Phelps & McNamara, P.C.
- -
- Emory University School of Law
- J.D. | Law
- -
- Emory University
- M.P.H | Health Policy and Management
- -
- Sweet Briar College
- B.A. | Government
- -
- Honors: Honors Degree with High Honors; summa cum laude; Phi Beta Kappa
- Rising Star
- SuperLawyers
- Named a Rising Star in Food & Drug Law in Washington, DC
- Dean's Public Service Award
- Emory University School of Law
- Phi Beta Kappa
- Sweet Briar College
- Presidential Medal
- Sweet Briar College
- Food & Drug Law Institute
- Member
- - Current
- Women Owned Law
- Member
- - Current
- District of Columbia Bar
- Member
- - Current
- State Bar of Georgia
- Member
- - Current
- Food & Drug Law Institute
- Editorial Advisory Board Member, Food and Drug Law Journal
- -
- "In Vitro Diagnostics Submissions and Compliance," in Fundamentals of U.S. Regulatory Affairs, Sixth Edition
- Regulatory Affairs Professional Society
- "Environmental Health and Protection," in Law And Public Health Practice, Second Edition Edition
- Oxford University Press
- "Clinical Trials Disclosure Requirements: Too Much of a Good Thing?"
- RA Focus
- "Courts Scrutinize FDA 'Disgorgement' Demands"
- Washington Legal Foundation Legal Backgrounder
- "Qualified Health Claims: Creatures of Case Law"
- FDLI Update
- "Dissecting the VALID Act", Diagnostic Coverage & Reimbursement Conference, Chicago, IL
- Q1 Productions
- "Telemedicine and Remote Patient Monitoring: Public Health Emergency Next Steps & Associated Costs", Medical Device Coverage & Reimbursement Conference, Chicago, IL
- Q1 Productions
- "Dissecting the VALID Act", Diagnostic Coverage & Reimbursement Conference, Boston, MA
- Q1 Productions
- Moderator, “Preparing for the Next Public Health Crisis: Implementing a Culture-Centered Approach to Collaborative Communication Efforts by the FDA and CDC", The Interconnected Regulatory Landscape: Exploring FDA’s Relationship with Other Domestic Regulators, Virtual
- Food and Drug Law Journal
- "What Post-Marketing Issues Should I Be Considering?", Fundamentals of Digital Health Regulation: Successfully Navigating Your Product Through FDA
- Food and Drug Law Institute
- Website
- Penn Avenue Law & Policy
There are no recently viewed profiles.
There are no saved profiles.
There are no profiles to compare.